Dual action of palmitoyl trifluoromethyl ketone (PACOCF3) on Ca2+ signaling: activation of extracellular Ca2+ influx and alteration of ATP- and bradykinin-induced Ca2+ responses in Madin Darby canine kidney cells

Arch Toxicol. 2000 Oct;74(8):447-51. doi: 10.1007/s002040000130.

Abstract

The effect of the phospholipase A2 inhibitor palmitoyl trifluoromethyl ketone (PACOCF3) on Ca2+ signaling in Madin Darby canine kidney (MDCK) cells was examined using fura-2 as the fluorescent Ca2+ indicator. At a concentration of 20 microM, PACOCF3 did not change basal cytosolic free calcium concentrations ([Ca2+]i), but at concentrations of 50-250 microM PACOCF3 induced an increase in [Ca2+]i by activating extracellular Ca2+ entry which was partly suppressed by 50 microM La3+. The effect of PACOCF3 was abolished by removal of extracellular Ca2+. PACOCF3 (10 microM) enhanced both the peak value and the area under the curve of the [Ca2+]i increase induced by 10 microM ATP and 1 microM bradykinin by potentiating extracellular Ca2+ influx without affecting internal Ca2+ release. Several other phospholipase A2 inhibitors had no effect on basal [Ca2+]i or agonist-induced [Ca2+]i increases. Collectively, the results suggest that PACOCF3 alters Ca2+ signaling in renal tubular cells in a manner independent of phospholipase A2 inhibition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology*
  • Animals
  • Bradykinin / pharmacology*
  • Calcium / metabolism*
  • Calcium Signaling / drug effects*
  • Cell Line
  • Dogs
  • Enzyme Inhibitors / pharmacology*
  • Ketones / pharmacology*
  • Kidney / metabolism
  • Lanthanum / pharmacology
  • Phospholipases A / antagonists & inhibitors*
  • Phospholipases A / physiology
  • Phospholipases A2

Substances

  • Enzyme Inhibitors
  • Ketones
  • palmitoyl trifluoromethyl ketone
  • Lanthanum
  • Adenosine Triphosphate
  • Phospholipases A
  • Phospholipases A2
  • Bradykinin
  • Calcium